Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand? (Q37408133)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

review article

1 reference

title

Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

main subject

biomarker

0 references

Guillain–Barré syndrome

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

4

Hayrettin Tumani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Johannes Brettschneider

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

Sigurd Süssmuth

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

volume

256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

3-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

Purification and properties of a brain-specific protein, human 14-3-3 protein.

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00415-009-0097-X

Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-009-0097-X

Quality of life complements traditional outcome measures in immune-mediated polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-009-0097-X

CSF hypocretin levels in Guillain–Barré syndrome and other inflammatory neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-009-0097-X

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-009-0097-X

Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-009-0097-X

Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-009-0097-X

Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies

21 January 2018

1 reference

12 December 2020

Expression of TNFalpha and TGFbeta1 in Guillain-Barré syndrome: correlation of a low TNFalpha-/TGFbeta1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment

1 reference

12 December 2020

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

12 December 2020

A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review

1 reference

12 December 2020

Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.

1 reference

12 December 2020

A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value

1 reference

12 December 2020

Guillain-Barré syndrome: activated complement components C3a and C5a in CSF

1 reference

12 December 2020

Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients

1 reference

12 December 2020

CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system

1 reference

12 December 2020

Ultrastructural observations in Guillain-Barre syndrome

1 reference

12 December 2020

The Anatomy of the Blood Brain Barrier: A Review

1 reference

12 December 2020

Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

Ganglioside complexes as new target antigens in Guillain-Barré syndrome

1 reference

12 December 2020

Clinical signs in severe Guillain-Barré syndrome: analysis of 63 patients

1 reference

12 December 2020

REporting recommendations for tumour MARKer prognostic studies (REMARK)

1 reference

12 December 2020

Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation

1 reference

12 December 2020

Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS)

1 reference

12 December 2020

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

1 reference

12 December 2020

Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barre syndrome

1 reference

12 December 2020

Detection of neuron specific enolase concentrations in cerebrospinal fluid from patients with neurological disorders by means of a sensitive enzyme immunoassay

1 reference

12 December 2020

Increased CSF C4d in demyelinating neuropathy indicates the radicular involvement

1 reference

12 December 2020

Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

Molecular mimicry in Guillain-Barré syndrome.

1 reference

12 December 2020

Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

1 reference

12 December 2020

Residua of Guillain-Barré Polyneuritis in Children

1 reference

12 December 2020

Early electrodiagnostic findings in Guillain-Barré syndrome

1 reference

12 December 2020

The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture

1 reference

12 December 2020

Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.

1 reference

12 December 2020

A specific ELISA for measuring neurofilament heavy chain phosphoforms

1 reference

12 December 2020

Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain

1 reference

12 December 2020

Guillain-Barré syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnoses.

1 reference

12 December 2020

Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases

1 reference

12 December 2020

Diagnostic and classification criteria for the Guillain-Barré syndrome

1 reference

12 December 2020

Campylobacter jejuni infection and Guillain-Barré syndrome.

1 reference

12 December 2020

Guidelines for the next 10 years of proteomics

1 reference

12 December 2020

Cerebrospinal fluid protein concentrations related to clinical findings in patients with sciatica caused by disk herniation

1 reference

12 December 2020

Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders

1 reference

12 December 2020

Cerebrospinal fluid and serum antiphospholipid antibodies in multiple sclerosis, Guillain-Barré syndrome and systemic lupus erythematosus

1 reference

12 December 2020

CSF neurofilament levels: a potential prognostic marker in Guillain-Barré syndrome

1 reference

12 December 2020

Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children

1 reference

12 December 2020

S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

1 reference

12 December 2020

The polypeptide composition of moving and stationary neurofilaments in cultured sympathetic neurons

1 reference

12 December 2020

Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome

1 reference

12 December 2020

The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome

1 reference

12 December 2020

CSF tau protein: a new prognostic marker for Guillain-Barré syndrome

1 reference

12 December 2020

Prognostic factors in Guillain-Barre' syndrome

1 reference

12 December 2020

Detection of CSF 14-3-3 protein in Guillain-Barré syndrome.

1 reference

12 December 2020

Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases

1 reference

12 December 2020

Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis

1 reference

12 December 2020

Demonstration of oligoclonal immunoglobulin G in Guillain-Barr� syndrome and lymphocytic meningoradiculitis by isoelectric focusing

1 reference

12 December 2020

Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology

1 reference

12 December 2020

Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.

1 reference

12 December 2020

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome

1 reference

12 December 2020

Guillain-Barre syndrome in Taiwan: a clinical study of 167 patients

1 reference

12 December 2020

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

1 reference

12 December 2020

Early predictors of incomplete recovery in children with Guillain-Barré polyneuritis

1 reference

12 December 2020

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

1 reference

12 December 2020

The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease

1 reference

12 December 2020

Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis

1 reference

12 December 2020

Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP

1 reference

12 December 2020

Controlled trial prednisolone in acute polyneuropathy

1 reference

12 December 2020

Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system

1 reference

12 December 2020

An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid.

1 reference

12 December 2020

Peripheral neuropathies and anti-glycolipid antibodies

1 reference

12 December 2020

Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders

1 reference

12 December 2020

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

1 reference

12 December 2020

Prognostic value of cerebrospinal fluid neuron-specific enolase and S-100b protein in Guillain-Barré syndrome

1 reference

12 December 2020

Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species.

1 reference

12 December 2020

Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.

1 reference

12 December 2020

Pathology of the Guillain-Barr� syndrome

1 reference

12 December 2020

10.1007/S00415-009-0097-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19267167 AND SRC:MED&resulttype=core&format=json

22 January 2020

1 reference